2096 — Simcere Pharmaceutical Cashflow Statement
0.000.00%
- HK$21.51bn
- HK$20.73bn
- CNY6.64bn
- 77
- 28
- 97
- 79
Annual cashflow statement for Simcere Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 805 | 1,402 | 886 | 740 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -213 | -1,072 | 97.5 | 58.4 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -718 | -784 | 86.7 | -957 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 96.7 | -202 | 1,354 | 151 | — |
Capital Expenditures | -353 | -209 | -678 | -980 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 882 | -226 | 746 | 2,068 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 529 | -436 | 68.3 | 1,088 | — |
Financing Cash Flow Items | -996 | 245 | -46 | -35.5 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,354 | -1,625 | -754 | -895 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,915 | -2,297 | 684 | 349 | — |